ACRS
Aclaris Therapeutics·NASDAQ
--
--(--)
--
--(--)
ACRS fundamentals
Aclaris Therapeutics (ACRS) released its earnings on Aug 7, 2025: revenue was 1.78M (YoY -35.76%), beat estimates; EPS was -0.13 (YoY +13.33%), beat estimates.
Revenue / YoY
1.78M
-35.76%
EPS / YoY
-0.13
+13.33%
Report date
Aug 7, 2025
EPS
Actual | -0.37 | -0.28 | -0.25 | -0.3 | -0.57 | -0.34 | -0.35 | -0.37 | -0.31 | -0.31 | -0.3 | -0.41 | -0.42 | -0.42 | -0.41 | -0.02 | -0.24 | -0.15 | -0.11 | -1.01 | -0.12 | -0.13 | |||||||||||
Forecast | -0.375 | -0.355 | -0.3125 | -0.3075 | -0.304 | -0.275 | -0.2817 | -0.365 | -0.3933 | -0.3583 | -0.3912 | -0.4453 | -0.4369 | -0.4501 | -0.4798 | -0.3444 | -0.2857 | -0.2047 | -0.0057 | -0.2867 | -0.1522 | -0.1329 | |||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +1.33% | +21.13% | +20.00% | +2.44% | -87.50% | -23.64% | -24.25% | -1.37% | +21.18% | +13.48% | +23.31% | +7.93% | +3.87% | +6.69% | +14.55% | +94.19% | +16.00% | +26.72% | -1829.82% | -252.28% | +21.16% | +2.18% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.41M | 2.05M | 1.45M | 1.58M | 1.78M | 1.80M | 1.66M | 1.50M | 1.45M | 1.53M | 19.02M | 7.75M | 2.53M | 1.87M | 9.28M | 17.57M | 2.40M | 2.77M | 4.35M | 9.21M | 1.46M | 1.78M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.13M | 1.23M | 1.47M | 1.39M | 1.48M | 1.75M | 1.77M | 1.79M | 1.60M | 1.61M | 1.60M | 1.99M | 1.75M | 1.90M | 1.57M | 4.66M | 1.93M | 1.82M | 1.57M | 2.11M | 2.96M | 1.37M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +25.07% | +66.54% | -1.40% | +13.69% | +19.86% | +3.08% | -6.31% | -16.20% | -9.10% | -5.20% | +1087.99% | +288.82% | +44.59% | -1.60% | +489.83% | +277.34% | +24.33% | +52.23% | +175.94% | +337.06% | -50.92% | +29.44% |
Earnings Call
You can ask Aime
What does Aclaris Therapeutics do and what are its main business segments?What were the key takeaways from Aclaris Therapeutics’s earnings call?What were the key takeaways from Aclaris Therapeutics's earnings call?Did Aclaris Therapeutics beat or miss consensus estimates last quarter?What guidance did Aclaris Therapeutics's management provide for the next earnings period?What factors drove the changes in Aclaris Therapeutics's revenue and profit?What is the market's earnings forecast for Aclaris Therapeutics next quarter?What is Aclaris Therapeutics's latest dividend and current dividend yield?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
